BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Motta NAV, Autran LJ, Brazão SC, Lopes RO, Scaramello CBV, Lima GF, Brito FCF. Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol 2021;92:107336. [PMID: 33418248 DOI: 10.1016/j.intimp.2020.107336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 de Havenon A, Sheth KN, Madsen TE, Johnston KC, Turan TN, Toyoda K, Elm JJ, Wardlaw JM, Johnston SC, Williams OA, Shoamanesh A, Lansberg MG. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. Stroke 2021;52:e635-45. [PMID: 34517768 DOI: 10.1161/STROKEAHA.121.035002] [Reference Citation Analysis]
2 Six I, Guillaume N, Jacob V, Mentaverri R, Kamel S, Boullier A, Slama M. The Endothelium and COVID-19: An Increasingly Clear Link Brief Title: Endotheliopathy in COVID-19. IJMS 2022;23:6196. [DOI: 10.3390/ijms23116196] [Reference Citation Analysis]
3 Mokra D, Mokry J. Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives? Int J Mol Sci 2021;22:1929. [PMID: 33669167 DOI: 10.3390/ijms22041929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Jakubowska E, Milanowski B, Lulek J. A Systematic Approach to the Development of Cilostazol Nanosuspension by Liquid Antisolvent Precipitation (LASP) and Its Combination with Ultrasound. Int J Mol Sci 2021;22:12406. [PMID: 34830298 DOI: 10.3390/ijms222212406] [Reference Citation Analysis]